Neuropace, Inc. NPCE EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s EBITDA?
- Neuropace, Inc. (NPCE) reported EBITDA of -$5.51M in Q1 2026.
- How has Neuropace, Inc.'s EBITDA changed year-over-year?
- Neuropace, Inc.'s EBITDA decreased by 8.0% year-over-year, from -$5.1M to -$5.51M.
- What is the long-term trend for Neuropace, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s EBITDA has grown at a -9.0% compound annual growth rate (CAGR), from -$23.38M to -$16.01M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.